Literature DB >> 10891479

Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells.

M Arsura1, F Mercurio, A L Oliver, S S Thorgeirsson, G E Sonenshein.   

Abstract

NF-kappaB/Rel factors have been implicated in the regulation of liver cell death during development, after partial hepatectomy, and in hepatocytes in culture. Rat liver epithelial cells (RLEs) display many biochemical and ultrastructural characteristics of oval cells, which are multipotent cells that can differentiate into mature hepatocytes. While untransformed RLEs undergo growth arrest and apoptosis in response to transforming growth factor beta1 (TGF-beta1) treatment, oncogenic Ras- or Raf-transformed RLEs are insensitive to TGF-beta1-mediated growth arrest. Here we have tested the hypothesis that Ras- or Raf-transformed RLEs have altered NF-kappaB regulation, leading to this resistance to TGF-beta1. We show that classical NF-kappaB is aberrantly activated in Ras- or Raf-transformed RLEs, due to increased phosphorylation and degradation of IkappaB-alpha protein. Inhibition of NF-kappaB activity with a dominant negative form of IkappaB-alpha restored TGF-beta1-mediated cell killing of transformed RLEs. IKK activity mediates this hyperphosphorylation of IkappaB-alpha protein. As judged by kinase assays and transfection of dominant negative IKK-1 and IKK-2 expression vectors, NF-kappaB activation by Ras appeared to be mediated by both IKK-1 and IKK-2, while Raf-induced NF-kappaB activation was mediated by IKK-2. NF-kappaB activation in the Ras-transformed cells was mediated by both the Raf and phosphatidylinositol 3-kinase pathways, while in the Raf-transformed cells, NF-kappaB induction was mediated by the mitogen-activated protein kinase cascade. Last, inhibition of either IKK-1 or IKK-2 reduced focus-forming activity in Ras-transformed RLEs. Overall, these studies elucidate a mechanism that contributes to the process of transformation of liver cells by oncogene Ras and Raf through the IkappaB kinase complex leading to constitutive activation of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891479      PMCID: PMC85990          DOI: 10.1128/MCB.20.15.5381-5391.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  78 in total

1.  Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.

Authors:  R E Bellas; M J FitzGerald; N Fausto; G E Sonenshein
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

Authors:  J D Woronicz; X Gao; Z Cao; M Rothe; D V Goeddel
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

4.  Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.

Authors:  M Arsura; M J FitzGerald; N Fausto; G E Sonenshein
Journal:  Cell Growth Differ       Date:  1997-10

5.  Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates.

Authors:  D K Giri; B B Aggarwal
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

6.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

Authors:  M W Mayo; C Y Wang; P C Cogswell; K S Rogers-Graham; S W Lowe; C J Der; A S Baldwin
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

7.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Authors:  R C Bargou; F Emmerich; D Krappmann; K Bommert; M Y Mapara; W Arnold; H D Royer; E Grinstein; A Greiner; C Scheidereit; B Dörken
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

8.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Authors:  M A Sovak; R E Bellas; D W Kim; G J Zanieski; A E Rogers; A M Traish; G E Sonenshein
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

9.  p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.

Authors:  A Kalkuhl; J Troppmair; A Buchmann; S Stinchcombe; C L Buenemann; U R Rapp; K Kaestner; M Schwarz
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

10.  Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases.

Authors:  R Geleziunas; S Ferrell; X Lin; Y Mu; E T Cunningham; M Grant; M A Connelly; J E Hambor; K B Marcu; W C Greene
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more
  23 in total

Review 1.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β)-induced suppressor effects in hepatocytes.

Authors:  Conrad Ortiz; Laia Caja; Esther Bertran; Águeda Gonzalez-Rodriguez; Ángela M Valverde; Isabel Fabregat; Patricia Sancho
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

3.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.

Authors:  Haoqiang Ying; Kutlu G Elpek; Anant Vinjamoori; Stephanie M Zimmerman; Gerald C Chu; Haiyan Yan; Eliot Fletcher-Sananikone; Hailei Zhang; Yingchun Liu; Wei Wang; Xiaojia Ren; Hongwu Zheng; Alec C Kimmelman; Ji-hye Paik; Carol Lim; Samuel R Perry; Shan Jiang; Brian Malinn; Alexei Protopopov; Simona Colla; Yonghong Xiao; Aram F Hezel; Nabeel Bardeesy; Shannon J Turley; Y Alan Wang; Lynda Chin; Sarah P Thayer; Ronald A DePinho
Journal:  Cancer Discov       Date:  2011-05-23       Impact factor: 39.397

4.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

5.  Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.

Authors:  Sébastien Jeay; Stefania Pianetti; Herbert M Kagan; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation.

Authors:  Sanghoon Lee; Charlotte Andrieu; Frédéric Saltel; Olivier Destaing; Jessie Auclair; Véronique Pouchkine; Jocelyne Michelon; Bruno Salaun; Ryuji Kobayashi; Pierre Jurdic; Elliott D Kieff; Bakary S Sylla
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

7.  IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.

Authors:  Song Gao; Yan Sun; Xuebin Zhang; Limei Hu; Yuexin Liu; Corrine Yingxuan Chua; Lynette M Phillips; He Ren; Jason B Fleming; Huamin Wang; Paul J Chiao; Jihui Hao; Wei Zhang
Journal:  Cancer Res       Date:  2016-09-22       Impact factor: 12.701

8.  Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.

Authors:  Raphaëlle Romieu-Mourez; Dong W Kim; Sang Min Shin; Elizabeth G Demicco; Esther Landesman-Bollag; David C Seldin; Robert D Cardiff; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Comprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysis.

Authors:  W-Y Cheng; J-C Lien; C-Y Hsiang; S-L Wu; C-C Li; H-Y Lo; J-C Chen; S-Y Chiang; J-A Liang; T-Y Ho
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

10.  Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells.

Authors:  Bing Tian; Yuhong Zhang; Bruce A Luxon; Roberto P Garofalo; Antonella Casola; Mala Sinha; Allan R Brasier
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.